Scopolamine regulates the osteogenic differentiation of human periodontal ligament stem cells through lactylation modification of RUNX2 protein

Abstract Periodontal ligament stem cells (PDLSCs) are important mesenchymal stem cells contributing to regenerating lost periodontal tissues and repairing bone defects. Studies on the molecular mechanism affecting the osteogenic differentiation of PDLSCs are necessary. Scopolamine (SCO) is known as...

Full description

Bibliographic Details
Main Authors: Ying Wu, Pan Gong
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Pharmacology Research & Perspectives
Subjects:
Online Access:https://doi.org/10.1002/prp2.1169
_version_ 1797305090772566016
author Ying Wu
Pan Gong
author_facet Ying Wu
Pan Gong
author_sort Ying Wu
collection DOAJ
description Abstract Periodontal ligament stem cells (PDLSCs) are important mesenchymal stem cells contributing to regenerating lost periodontal tissues and repairing bone defects. Studies on the molecular mechanism affecting the osteogenic differentiation of PDLSCs are necessary. Scopolamine (SCO) is known as a regulator of neural cell damage. The focus of the current study is on unveiling the role of SCO‐mediated molecular mechanism in the osteogenic differentiation of PDLSCs. Through CCK‐8 assay and LDH detection, we confirmed that SCO enhanced the viability of PDLSCs. Moreover, we determined that SCO induced the PDLSCs osteogenic differentiation, according to data of ALP activity measurement and ARS staining. Mechanistically, we performed western blot and identified that SCO could promote the lactylation of runt‐related transcription factor 2 (RUNX2). We also found through rescue assays that knockdown of RUNX2 could reverse the effect of SCO treatment on the osteogenic differentiation of PDLSCs. Further mechanism investigation revealed that lactylation of RUNX2 at K176 site enhances the protein stability of RUNX2 through deubiquitination. Collectively, our present study unveils that SCO stabilizes RUNX2 to promote the osteogenic differentiation of PDLSCs through the lactylation modification of RUNX2.
first_indexed 2024-03-08T00:20:52Z
format Article
id doaj.art-4f842fd7f9804262aa46734a2ebccdf2
institution Directory Open Access Journal
issn 2052-1707
language English
last_indexed 2024-03-08T00:20:52Z
publishDate 2024-02-01
publisher Wiley
record_format Article
series Pharmacology Research & Perspectives
spelling doaj.art-4f842fd7f9804262aa46734a2ebccdf22024-02-16T09:36:32ZengWileyPharmacology Research & Perspectives2052-17072024-02-01121n/an/a10.1002/prp2.1169Scopolamine regulates the osteogenic differentiation of human periodontal ligament stem cells through lactylation modification of RUNX2 proteinYing Wu0Pan Gong1Department of Periodontics Affiliated Stomatology Hospital of Guangzhou Medical University Guangzhou ChinaDepartment of Stomatology Affiliated Cancer Hospital & Institute of Guangzhou Medical University Guangzhou ChinaAbstract Periodontal ligament stem cells (PDLSCs) are important mesenchymal stem cells contributing to regenerating lost periodontal tissues and repairing bone defects. Studies on the molecular mechanism affecting the osteogenic differentiation of PDLSCs are necessary. Scopolamine (SCO) is known as a regulator of neural cell damage. The focus of the current study is on unveiling the role of SCO‐mediated molecular mechanism in the osteogenic differentiation of PDLSCs. Through CCK‐8 assay and LDH detection, we confirmed that SCO enhanced the viability of PDLSCs. Moreover, we determined that SCO induced the PDLSCs osteogenic differentiation, according to data of ALP activity measurement and ARS staining. Mechanistically, we performed western blot and identified that SCO could promote the lactylation of runt‐related transcription factor 2 (RUNX2). We also found through rescue assays that knockdown of RUNX2 could reverse the effect of SCO treatment on the osteogenic differentiation of PDLSCs. Further mechanism investigation revealed that lactylation of RUNX2 at K176 site enhances the protein stability of RUNX2 through deubiquitination. Collectively, our present study unveils that SCO stabilizes RUNX2 to promote the osteogenic differentiation of PDLSCs through the lactylation modification of RUNX2.https://doi.org/10.1002/prp2.1169lactylationosteogenic differentiationPDLSCRUNX2scopolamine
spellingShingle Ying Wu
Pan Gong
Scopolamine regulates the osteogenic differentiation of human periodontal ligament stem cells through lactylation modification of RUNX2 protein
Pharmacology Research & Perspectives
lactylation
osteogenic differentiation
PDLSC
RUNX2
scopolamine
title Scopolamine regulates the osteogenic differentiation of human periodontal ligament stem cells through lactylation modification of RUNX2 protein
title_full Scopolamine regulates the osteogenic differentiation of human periodontal ligament stem cells through lactylation modification of RUNX2 protein
title_fullStr Scopolamine regulates the osteogenic differentiation of human periodontal ligament stem cells through lactylation modification of RUNX2 protein
title_full_unstemmed Scopolamine regulates the osteogenic differentiation of human periodontal ligament stem cells through lactylation modification of RUNX2 protein
title_short Scopolamine regulates the osteogenic differentiation of human periodontal ligament stem cells through lactylation modification of RUNX2 protein
title_sort scopolamine regulates the osteogenic differentiation of human periodontal ligament stem cells through lactylation modification of runx2 protein
topic lactylation
osteogenic differentiation
PDLSC
RUNX2
scopolamine
url https://doi.org/10.1002/prp2.1169
work_keys_str_mv AT yingwu scopolamineregulatestheosteogenicdifferentiationofhumanperiodontalligamentstemcellsthroughlactylationmodificationofrunx2protein
AT pangong scopolamineregulatestheosteogenicdifferentiationofhumanperiodontalligamentstemcellsthroughlactylationmodificationofrunx2protein